Navigation Links
Mindray Announces First Quarter 2009 Financial Results
Date:5/11/2009

Pass code for all regions: Mindray

A replay of the conference call may be accessed by phone at the following numbers until May 23, 2009.

    U.S. Toll Free: +1-888-286-8010
    International:  +1-617-801-6888
    Pass code:      9482 5654

Additionally, a live and archived webcast of this conference call will be available on the Investor Relations section of Mindray's website at http://www.mindray.com .

Use of Non-GAAP Financial Measures

The company has reported for the first quarter 2009 and provided estimates for full year 2009 net income and earning per share on a non-GAAP basis. Each of the terms as used by the company is defined as follows:

    -- Non-GAAP gross profit represents gross profit reported in accordance
       with GAAP, adjusted for the effects of share-based compensation and
       amortization of acquired intangible assets.
    -- Non-GAAP operating income represents operating income reported in
       accordance with GAAP, adjusted for the effects of share-based
       compensation and amortization of acquired intangible assets including,
       but not limited to, termination payments.
    -- Non-GAAP net income represents net income reported in accordance with
       GAAP, adjusted for the effects of share-based compensation and
       amortization of acquired intangible assets including, but not limited
       to, termination payments, all net of related tax impact.
    -- Non-GAAP earnings per share represents non-GAAP net income divided by
       the number of shares used in computing basic and diluted earnings per
       share in accordance with GAAP, and excludes the impact of the deemed
       dividends for the basic calculation.

In addition to Mindray's consolidated financial results under GAAP, the Company also provides non-GAAP financial measures, incl
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
3. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
4. Mindray Announces Option Exchange Offer
5. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
6. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
7. Mindray Announces Preliminary 2008 Operating Results
8. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference
9. Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
10. Mindray Announces 2008 Third Quarter and Nine Months Results
11. Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...., Nov. 9 - The U.S. Cen...ntly awarded the Pennsylvania Coalition Against Ra...o continue funding its National Sexual Violence Re...he NSVRC since 2000 to serve as the nation,s princ...g, and sharing information and resources about all...
(Date:11/9/2009)... Madeleines to the overbearing food critic in the ...ildhood at the aroma of stew, artists have long be...trong memories. Scientists at the Weizmann Institu...is of this connection. Their research appeared in ...te student Yaara Yeshurun, together with Profs. No...
(Date:11/9/2009)...those hurt are under 16, researchers say , ...juries have skyrocketed in the United States in re... 2007, a new study has found. , However, the t...ategory that includes whirlpools and spas -- remai...ut half of the injuries were caused by slips and f...
(Date:11/9/2009)..., Nov. 9 Renewal Laboratories anno... process to produce functional beverages with impo...al, nutritionally important supplements such as Co...ow be offered in appealing and refreshing drinks. ... of all natural drinks that can help maintain card...
(Date:11/9/2009)... On Tuesday November 10th, at 5:30 pm CS...g a lecture on Radiation Therapy Options for Mesot...ia teleconference, and via the mesocare.org websit...s) November 9, 2009 -- Mesothelioma lecture on T...org is sponsoring a lecture by Veronica Garza of M...
Breaking Medicine News(10 mins):Health News:CDC Awards Vital Prevention Funding to National Sexual Violence Resource Center 2Health News:Sniffing out memories 2Health News:Hot-Tub Injuries on the Rise 2Health News:Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health 2
...vival increase according to stage of disease, a ne... issue of CANCER, a peer-reviewed journal of the A...f survival data demonstrates that within each stag...inical factors the racial disparities in survival ...
...ditorial, to be published in the international jou...sevierhealth.com/journals/joca/ ), published by El...recommended that coxibs and nonsteroidal anti-infl...an international workshop organized by the Osteoar...
...en a routine visit to the family doctor includes a...ing Alzheimer’s disease (AD). If the test returns ...ns that might begin to gum up memory and thought i...hers at Mayo Clinic’s campus in Jacksonville aims ...
...ts who do not respond to traditional therapy can b...l transplant, according to an Indiana University S...he New England Journal of Medicine. About 90 p...tment of this disease by Lawrence Einhorn, M.D., a...
...eached 'epidemic' levels for the second time in th...ay said. The Ministry of Health said 381 ...the 'epidemic threshold' of 378 cases per week. ... ministry said. Singapore experienced its ...
...rth of the first baby to be produced from an egg, ... and defrosted for later use. The news pr...failure or who cannot be administered drugs that h...ductive Centre in Montreal. The baby's mother has ...
Other Medicine News:Health News:Survival differences by race most apparent in advanced stages of breast cancer 2Health News:Using coxibs and NSAIDs to treat osteoarthritis 2Health News:A new century of Alzheimer's disease research 2Health News:A new century of Alzheimer's disease research 3Health News:A new century of Alzheimer's disease research 4Health News:A new century of Alzheimer's disease research 5Health News:A new century of Alzheimer's disease research 6Health News:A new century of Alzheimer's disease research 7Health News:A new century of Alzheimer's disease research 8Health News:A new century of Alzheimer's disease research 9Health News:A new century of Alzheimer's disease research 10Health News:A new century of Alzheimer's disease research 11Health News:A new century of Alzheimer's disease research 12Health News:A new century of Alzheimer's disease research 13Health News:A new century of Alzheimer's disease research 14Health News:A new century of Alzheimer's disease research 15Health News:A new century of Alzheimer's disease research 16Health News:A new century of Alzheimer's disease research 17Health News:Advanced therapy offers cure for relapsed cancer patient 2Health News:First Baby Born from Eggs Matured and Frozen in the Lab 2
(Date:11/9/2009)... 9 Bend Research Inc., a company,w...nnovative pharmaceutical,technologies to help clie...nical problems, announced today that it has entere... Incorporated, a global biotechnology company,head...s new collaboration, Vertex will utilize Bend,s fo...
(Date:11/8/2009)...e of Health Care Reform Bill ,, Critical legi...e for all Americans ,, BOISE, Idaho, Nov. 7 ... House of Representatives passed critical health c...are for seniors and end discrimination by insuranc...of affordable health coverage. ,, The Afforda...
(Date:11/6/2009)...ire-FirstCall/ -- Recession in domestic and intern...ied Healthcare Products in the first quarter of fi...les declines pushed Allied into a loss for the qua...,000, or negative 9 cents per share, compared to a... 3 cents per share. ,, Sales fell about 21 per...
Breaking Medicine Technology:Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Smart for Life 28TM 29 Featured in Womans World Magazine 51752 1Smart for Life 28TM 29 Featured in Womans World Magazine 51752 2Oncolytics Biotech 28R 29 Inc Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting 13038 1Oncolytics Biotech 28R 29 Inc Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting 13038 2Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 1Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 2Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 3
...lts at 2007 American Association for,Cancer Resear...wswire-FirstCall/ -- Cleveland,BioLabs, Inc. , ann... CBLB502,s efficacy as a mitigator of both,gastroi...d,production) radiation-induced damage in non-huma..., Andrei Gudkov, Ph.D, D. Sci.,will present resul...
...ESS WIRE)--Apr 9, 2007 -,GlaxoSmithKline (LSE and ...ay announced data from Study 767905/014 and,provid...or,alvimopan (Entereg/Entrareg(R))., Study 014, a ...h) study, was designed to evaluate the long-term s...aily in patients taking,opioids for chronic non-ca...
Other Medicine Technology:Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 2Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 2GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 4GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 6GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 7
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: